This time around I was trying to decide which stock to purchase and it came down to three stocks, IBM, PEP, and JNJ. I think that I would be happy with any of these stocks here and all three are due for dividend increases next quarter. Johnson & Johnson had recently announced it's earnings and over the next couple days the stock sold off just enough to trigger my limit order. In hindsight I wish I would have waited a day to buy since the markets got hammered down nearly 300 points on friday then I could have picked up shares a bit cheaper but ohh well.
I purchased 11 shares of Johnson & Johnson (JNJ) at $99.99
As with my last purchase of PM, JNJ also is facing currency headwinds from a strong dollar. This really showed in the quarterly numbers but I am confident the company will return to growth soon enough.
Johnson & Johnson is a holding company, which is engaged in the research and development, manufacture and sale of products in the health care field within its Consumer, Pharmaceutical and Medical Devices, and Diagnostics business segments.
Johnson & Johnson (JNJ) Stock Chart
Johnson & Johnson (JNJ) Basic Statistics
- Ticker Symbol: JNJ
- PE Ratio: 17.5 (15.5 Forward p/e)
- Sector: Healthcare
- Yield: 2.8%
- Dividend Growth Streak: 52 years
- 5 Year Dividend Growth Rate: 7.3%
- Payout Ratio: 48 %
- Market cap: $277b
- Beta: .96
- Website: http://www.jnj.com
Johnson & Johnson (JNJ) EPS Growth Chart